Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-28

FDA Approved: DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Camber Pharmaceuticals' original application for a generic combination product of dextromethorphan hydrobromide and quinidine sulfate, indicate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextromethorphan hydrobromide and quinidine sulfate (Dextromethorphan hydrobromide and quinidine sulfate)

Snippet

ORIG AP for DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE (DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE)